In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 10th, 2008 | 28 | Yes |
Popular Name: Droperidol Droperidol
Find On: PubMed — Wikipedia — Google
CAS Numbers: 548-73-2 , 8067-59-2 , [548-73-2]
1-(1-(3-(p-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone
1-(1-(4-(p-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone
1-1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone
1-[1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone
1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone
2-Benzimidazolinone, 1-(1-(3-(p-fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-
2-Benzimidazolinone, 1-[1-[3-(p-fluorobenz
2-Benzimidazolinone, 1-[1-[3-(p-fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-
3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one
5-24-02-00388 (Beilstein Handbook Reference)
548-73-2; D00308; Droleptan (TN); Droperidol (JP16/USP/INN); Inapsine (TN)
548-73-2; Droperidol; Prestwick_705
8067-59-2; D03852; Droperidol - fentanyl citrate mixt; Innovar (TN)
CPD000058855; DROPERIDOL; SAM001247013
luorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone
oyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.40 | 9.39 | -17.93 | 1 | 5 | 0 | 58 | 379.435 | 6 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 9.66e-02 g/l | DrugBank-approved |
Indications | anesthetic, antiemetic, antipsychotic | KeyOrganics Bioactives |
Target | Dopamine Receptor | Selleck Chemicals |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Tocris Cookson Ltd.; NCC_SUPPLIER_STRUCTURE_ID : 101276 | NIH Clinical Collection via PubChem |
Therapy | neuroleptic | SMDC Iconix |
Target | Others | Selleck Chemicals |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Tocris Bioscience; SUPPLIER_STRUCTURE_ID: 101276 | NIH Clinical Collection via PubChem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
KCNH2-3-E | HERG (cluster #3 Of 5), Eukaryotic | Eukaryotes | 7490 | 0.26 | Binding ≤ 10μM |
SCN1A-1-E | Sodium Channel Protein Type I Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 740 | 0.31 | Binding ≤ 10μM |
SCN2A-2-E | Sodium Channel Protein Type II Alpha Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 740 | 0.31 | Binding ≤ 10μM |
SCN3A-1-E | Sodium Channel Protein Type III Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 740 | 0.31 | Binding ≤ 10μM |
SCN8A-1-E | Sodium Channel Protein Type VIII Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 740 | 0.31 | Binding ≤ 10μM |
KCNH2-1-E | HERG (cluster #1 Of 2), Eukaryotic | Eukaryotes | 32 | 0.37 | Functional ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 6310 | 0.26 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
KCNH2_HUMAN | Q12809 | HERG, Human | 32.3593657 | 0.37 | Binding ≤ 1μM |
SCN1A_HUMAN | P35498 | Sodium Channel Protein Type I Alpha Subunit, Human | 740 | 0.31 | Binding ≤ 1μM |
SCN2A_HUMAN | Q99250 | Sodium Channel Protein Type II Alpha Subunit, Human | 740 | 0.31 | Binding ≤ 1μM |
SCN3A_HUMAN | Q9NY46 | Sodium Channel Protein Type III Alpha Subunit, Human | 740 | 0.31 | Binding ≤ 1μM |
SCN8A_HUMAN | Q9UQD0 | Sodium Channel Protein Type VIII Alpha Subunit, Human | 740 | 0.31 | Binding ≤ 1μM |
KCNH2_HUMAN | Q12809 | HERG, Human | 32.3593657 | 0.37 | Binding ≤ 10μM |
SCN1A_HUMAN | P35498 | Sodium Channel Protein Type I Alpha Subunit, Human | 740 | 0.31 | Binding ≤ 10μM |
SCN2A_HUMAN | Q99250 | Sodium Channel Protein Type II Alpha Subunit, Human | 740 | 0.31 | Binding ≤ 10μM |
SCN3A_HUMAN | Q9NY46 | Sodium Channel Protein Type III Alpha Subunit, Human | 740 | 0.31 | Binding ≤ 10μM |
SCN8A_HUMAN | Q9UQD0 | Sodium Channel Protein Type VIII Alpha Subunit, Human | 740 | 0.31 | Binding ≤ 10μM |
KCNH2_HUMAN | Q12809 | HERG, Human | 32.2 | 0.37 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 3162.27766 | 0.28 | Functional ≤ 10μM |
Description | Species |
---|---|
Interaction between L1 and Ankyrins | |
Voltage gated Potassium channels |
No pre-computed analogs available. Try a structural similarity search.